Skip to main content

Advertisement

Log in

Short term results of cementless total hip arthroplasty in sicklers

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background: Sickle cell (SC) disease leading to endarteritis induces skeletal changes in the form of osteitis, sclerosis of femoral canal and osteonecrosis of the femoral head. All these make total hip arthroplasty (THA) difficult and prolonged. There is increased risk of infection, SC crisis and increased complication rate. Our paper aims to highlight preoperative, intraoperative and postoperative hurdles encountered in performing THA in sicklers and the short term outcome using cementless implants.

Materials and Methods: Thirty-nine patients with SC disease, who had osteonecrosis of the femoral head, were operated between 2007 and 2011. The mean age of patients was 22 years (range 13–49 years). There were twenty eight females and 11 males. Bilateral cementless total hip replacement (THR) was performed in 11 patients (22 hips) and in the rest unilateral (28 hips). Preoperative and postoperative modified Harris hip score was evaluated. The average followup was 3.8 years (range 2-6 years).

Results: The average operating time was 96 min (range 88–148 min). The average blood loss was 880 ml (range 650–1200 ml). The average intraoperative blood transfused was 2.3 units (range 2–5 units). All patients showed an improvement in Harris hip score from 42 points preoperatively to 92 points at latest followup. Intraoperatively, one patient had a periprosthetic fracture. Six patients developed acute SC crisis and were managed in intensive care unit. Three patients developed wound hematoma. Three patients developed limb length discrepancy less than 1 cm. None had early or late dislocations, infection, heterotopic ossification, sciatic nerve palsy and aseptic loosening.

Conclusion: THA in sicklers involves considerable challenge for the orthopedic surgeon. Management requires a multidisciplinary approach involving the anesthetist, hematologist and the orthopedic surgeon. Contrary to previous reports, THA in sicklers now has a predictable outcome especially with the use of cementless implants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chung SM, Alavi A, Russell MO. Management of osteonecrosis in sickle-cell anemia and its genetic variants. Clin Orthop Relat Res 1978;130:158–74.

    Google Scholar 

  2. Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD. Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br 1989;71:465–70.

    Article  CAS  Google Scholar 

  3. Hanker GJ, Amstutz HC. Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications. J Bone Joint Surg Am 1988;70:499–506.

    Article  CAS  Google Scholar 

  4. Hickman JM, Lachiewicz PF. Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies. Role of cementless components. J Arthroplasty 1997;12:420–5.

    Article  CAS  Google Scholar 

  5. Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the National Sickle Cell Surgery Study Group. Am J Hematol 1999;62:129–38.

    Article  CAS  Google Scholar 

  6. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br 1995;77:34–41.

    Article  CAS  Google Scholar 

  7. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am 1969;51:737–55.

    Article  CAS  Google Scholar 

  8. Hernigou P, Zilber S, Filippini P, Mathieu G, Poignard A, Galacteros F. Total THA in adult osteonecrosis related to sickle cell disease. Clin Orthop Relat Res 2008;466:300–8.

    Article  Google Scholar 

  9. Hernigou P, Galacteros F, Bachir D, Goutallier D. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am 1991;73:81–92.

    Article  CAS  Google Scholar 

  10. Ware HE, Brooks AP, Toye R, Berney SI. Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br 1991;73:947–9.

    Article  CAS  Google Scholar 

  11. Reynolds J. The Roentgenological Features of Sickle Cell Disease and Related Hemoglobinopathies. Springfield III: Charles C. Thomas; 1965.

    Google Scholar 

  12. Baumgaurd SH, Leach RE. Avascular necrosis of femoral head secondary to sickle cell disease: Case report of two Caucasian sisters. Clin Orthop 1970;69:207–12.

    Google Scholar 

  13. Gunderson C, D’Ambrosia RD, Shoji H. Total hip replacement in patients with sickle-cell disease. J Bone Joint Surg Am 1977;59:760–2.

    Article  CAS  Google Scholar 

  14. Al-Mousawi F, Malki A, Al-Aradi A, Al-Bagali M, Al-Sadadi A, Booz MM. Total hip replacement in sickle cell disease. Int Orthop 2002;26:157–61.

    Article  CAS  Google Scholar 

  15. Hug KT, Gupta AK, Wellman SS, Bolognesi MP, Attarian DE. Creation of a femoral cortical window to facilitate total hip arthroplasty in patients with sickle cell hemoglobinopathies. J Arthroplasty 2013;28:323–5.

    Article  Google Scholar 

  16. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 1984;311:7–12.

    Article  CAS  Google Scholar 

  17. Bishop AR, Roberson JR, Eckman JR, Fleming LL. Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy. J Bone Joint Surg Am 1988;70:853–5.

    Article  CAS  Google Scholar 

  18. Booz MM, Hariharan V, Aradi AJ, Malki AA. The value of ultrasound and aspiration in differentiating vaso-occlusive crisis and osteomyelitis in sickle cell disease patients. Clin Radiol 1999;54:636–9.

    Article  CAS  Google Scholar 

  19. Lifeso R. Total joint replacement in sickle cell disease. Orthop Trans 1985;9:453.

    Google Scholar 

  20. Sene M, Dansoko A, Ndiaye A, Mbaye E, Niang CD, Faye M. Total hip arthroplasty after avascular necrosis due to sickle cell disease in Senegal: Series of 48 replacements. Med Trop (Mars) 2009;69:573–6.

    CAS  Google Scholar 

  21. Ekere AU, Eze CB, Ebirim LN. A report of two cases of uncemented total hip replacement in patients with sickle cell disease. Niger J Clin Pract 2008;11:257–9.

    CAS  PubMed  Google Scholar 

  22. Issa K, Naziri Q, Maheshwari AV, Rasquinha VJ, Delanois RE, Mont MA. Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid term followup using cementless prosthetic components. J Arthroplasty 2013;28:1693–8.

    Article  Google Scholar 

  23. Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br 1992;74:367–71.

    Article  CAS  Google Scholar 

  24. Moran MC, Huo MH, Garvin KL, Pellicci PM, Salvati EA. Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop Relat Res 1993;294:140–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mrinal Sharma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gulati, Y., Sharma, M., Bharti, B. et al. Short term results of cementless total hip arthroplasty in sicklers. IJOO 49, 447–451 (2015). https://doi.org/10.4103/0019-5413.159659

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/0019-5413.159659

Key words

MeSH terms

Navigation